Trial intelligence / Profile preview

Levulan PDT after Cryotherapy for Actinic Keratosis

NCT02239679Phase 2Completed

Sponsor
DUSA Pharmaceuticals
Start
Sep 2014
Primary completion
Jul 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of aminolevulinic acid 10% gel in actinic keratosis (AK), sponsored by DUSA Pharmaceuticals. Started Sep 2014; status: completed.

02

Drugs

aminolevulinic acid 10% gel
03

Conditions

actinic keratosis (AK)

Beyond the preview

Go deeper on NCT02239679.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02239679.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call